immunoprecise antibodies (ipa) ceo jennifer bath - commercial launch of ai-driven drug discovery api
Published 2 months ago • 4.5K plays • Length 18:17Download video MP4
Download video MP3
Similar videos
-
7:30
nasdaq interview with ipa ceo, dr. jennifer bath - june 2023
-
8:12
ipa collective: webisode — neoepitope antibody discovery using fully human scfv libraries
-
12:59
from generative ai to human clinical trials: a story of insilico medicine's tnik program
-
1:31:54
bioverse episode 12 - artificial intelligence in drug development
-
6:09
artificial intelligence in drug discovery - 4 approaches biopharma industry is using!
-
4:37
ai in drug discovery - who owns the patents?
-
2:47
ai's role in antibody discovery
-
4:15
how ai is accelerating drug discovery
-
1:12
generative ai for drug discovery and design
-
5:32
unveiling the power of ai in drug discovery
-
2:24
accelerate ai-powered drug discovery with nvidia bionemo
-
3:32
monoclonal antibodies and its production
-
1:05
ai-driven drug discovery
-
17:01
ai in medicine: geometric deep learning for drug discovery and indication expansion
-
23:05
high throughput identification of genetically distinct, target-specific antibodies